Relations between Effects and Structure of Small Bicyclic Molecules on the Complex Model System Saccharomyces cerevisiae
暂无分享,去创建一个
Duccio Cavalieri | Matteo Brilli | Andrea Trabocchi | Irene Stefanini | D. Cavalieri | M. Brilli | A. Trabocchi | Tobias Weil | I. Stefanini | Tobias Weil | Irene Stefanini
[1] K. Mikkelsen,et al. Polarizability of molecular clusters as calculated by a dipole interaction model , 2002 .
[2] P. Clemons,et al. Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.
[3] A. Pupi,et al. 3-Aza-6,8-dioxabicyclo[3.2.1]octanes as new enantiopure heteroatom-rich tropane-like ligands of human dopamine transporter. , 2006, Bioorganic & medicinal chemistry.
[4] Feng Cong,et al. Chemical genetics-based target identification in drug discovery. , 2012, Annual review of pharmacology and toxicology.
[5] Anne-Béatrice Dufour,et al. The ade4 Package: Implementing the Duality Diagram for Ecologists , 2007 .
[6] A. Goffeau,et al. Identification and Characterization of SNQ2, a New Multidrug ATP Binding Cassette Transporter of the Yeast Plasma Membrane (*) , 1995, The Journal of Biological Chemistry.
[7] D C Swinney,et al. Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines , 2013, Clinical pharmacology and therapeutics.
[8] Andreas Bender,et al. Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.
[9] P. Filzmoser,et al. Redundancy analysis for characterizing the correlation between groups of variables - Applied to molecular descriptors , 2012 .
[10] J. Bajorath. Structure–Activity Relationship Data Analysis: Activity Landscapes and Activity Cliffs , 2013 .
[11] M. Ghannoum,et al. Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.
[12] D. Potenza,et al. Synthesis and conformational analysis of small peptides containing 6-endo-BT(t)L scaffolds as reverse turn mimetics. , 2002, The Journal of organic chemistry.
[13] Corey Nislow,et al. Yeast chemical genomics and drug discovery: an update. , 2008, Trends in pharmacological sciences.
[14] A. Trabocchi,et al. Synthesis and Reactivity of Bicycles Derived from Tartaric Acid and α-Amino Acids: A Novel Class of Conformationally Constrained Dipeptide Isosteres Based upon Enantiopure 3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic Acid , 1999 .
[15] Warren R. J. D. Galloway,et al. The Basics of Diversity‐Oriented Synthesis , 2013 .
[16] A. Rincón,et al. Increased biomass production of industrial bakers' yeasts by overexpression of Hap4 gene. , 2010, International journal of food microbiology.
[17] J. Mccusker,et al. Development of Saccharomyces Cerevisiae as a Model Pathogen: a System for the Genetic Identification of Gene Products Required for Survival in the Mammalian Host Environment Tion and Therefore Simultaneously Exposed to the Same , 2001 .
[18] A. Trabocchi,et al. A solid-phase approach towards the development of 3-aza-6,8-dioxabicyclo[3.2.1]octane scaffolds , 2004, Molecular Diversity.
[19] A. Trabocchi,et al. Structural diversity of bicyclic amino acids , 2007, Amino Acids.
[20] William N. Venables,et al. Modern Applied Statistics with S , 2010 .
[21] D. Swinney,et al. How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.
[22] C. Kappe,et al. Parallel synthesis of an amide library based on the 6,8-dioxa-3-azabicyclo[3.2.1]octane scaffold by direct aminolysis of methyl esters. , 2007, Journal of combinatorial chemistry.
[23] D. Cavalieri,et al. A Systems Biology Approach to Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants* , 2010, The Journal of Biological Chemistry.
[24] G. Schneider,et al. The State of the Art of Chemical Biology , 2009, Chembiochem : a European journal of chemical biology.
[25] K. Kuchler,et al. Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. , 2001, Research in microbiology.
[26] K. Śmietana,et al. Trends in clinical success rates , 2016, Nature Reviews Drug Discovery.
[27] S. Haggarty,et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] Charles Brenner,et al. Chemical genomics in yeast , 2004, Genome Biology.